HomeNewsBusinessEconomyFM Sitharaman says Centre in talks with RBI on one-time restructuring of loans

FM Sitharaman says Centre in talks with RBI on one-time restructuring of loans

The banking sector is likely to witness a major spike in NPAs going forward on account of COVID-19, which will impact the cash flows of companies and make the recovery process even more difficult

June 25, 2020 / 23:09 IST
Story continues below Advertisement

Finance Minister Nirmala Sitharaman on June 25 said the Centre is in talks with the Reserve Bank of India (RBI) on the subject of one-time restructuring of loans to provide relief to companies that are reeling under stress due to the unprecedented economic fallout from the COVID-19 pandemic.

Sitharaman said the Centre was also looking at why benefits of interest rate reductions were not being passed on to customers, Business Standard reported. The finance minister said at a webinar organised by the Chennai International Centre (CIC) that the proposal for a one-time loan restructuring option was being discussed by the Centre and the RBI.

Story continues below Advertisement

Also Read | SBI writes off loans worth Rs 1.79 lakh crore in last four years

The banking sector is likely to witness a major spike in non-performing assets (NPAs) going forward on account of the impact of COVID-19 on industries, which will, in turn, impact the cash flows of companies and make the recovery process even more difficult.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show